Sometime soon a slender robot that looks like Casper the ghost and works like Skype on wheels may visit the bedside of an Ebola patient in West Africa, as a doctor nearby instantly transmits data to other researchers over a portable Wi-Fi network.
This source of strategic partnership offers a synergistic relationship that combines monetary and functional resources, capabilities, and core competencies for the purpose of technology commercialization. Entrepreneurs who are looking to accelerate the growth of their businesses often realize they can capture a greater bang for their buck when they collaborate with CVCs who offer value beyond the dollar.
Louis Brandeis famously characterized states as laboratories for democracy, but cities could be called labs for innovation or new practices. With far fewer resources than states or the federal government and responsibilities to people on a daily basis, cities have to be scrappy and creative when it comes to delivering services and running their operations.
California has been associated with risk-taking, entrepreneurship and innovation since the Gold Rush. Today, California is still an innovation engine in such varied sectors as agriculture and the Internet. But only one homegrown industry can stake a claim as a leading contributor to our state’s economy and the health of people around the world: the life sciences sector.
Falls Church-based Northrop Grumman Corp. has named Kenneth Bedingfield as its next chief financial officer.
Bedingfield will succeed James Palmer, who retires next year.
A flood of new health care IT companies has been pouring into the U.S. health care market. The cause of this torrent: the recognition that as market and regulatory forces alter incentives in health care, IT companies will play a powerful role in combating the overemployment and declining productivity that has plagued this industry and in helping providers improve the quality of care.
GlaxoSmithKline (GSK) has for the fourth consecutive time been ranked No 1 among global pharmaceutical companies assessed for their efforts to improve access to medicine in developing countries.
Released on 17th November by the Access to Medicine Foundation, the 2014 Access to Medicine (ATM) Index gives GSK a composite score of 3.3 out of a possible 5, following an in-depth evaluation of company activities in seven areas that are germane to enhancing access to medicine in developing countries.
How do you turn a genetic disorder into a money-making empire? Grumpy Cat has done it, but is it only acceptable because she is a funny looking feline instead of a human?
Last week, the Department of Health and Human Services welcomed its third group of “entrepreneurs-in-residence” — mainly private-sector tech experts and start-up founders who are spending a year advising the agency on its health IT projects.
AstraZeneca became the latest biotechnology company to expand its manufacturing operations in Maryland when the British drugmaker announced plans last month to enlarge a production facility and add 300 workers in Frederick.